KALV - KalVista Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$28.67
DETAILS
HIGH:
$32.00
LOW:
$27.00
MEDIAN:
$27.00
CONSENSUS:
$28.67
UPSIDE:
6.19%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 91.7% |
| EBIT Margin | -206.6% |
| EBITDA Margin | -204.6% |
| Operating Margin | -233.4% |
| Pretax Margin | -232.9% |
| Cont. Ops Margin | -223.2% |
| Net Margin | -223.2% |
| Bottom Line Margin | -223.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 5.58 |
| Quick Ratio | 5.52 |
| Solvency Ratio | -0.482 |
| Cash Ratio | 4.00 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-5.00
Peers avg: 32.0
|
| PEG Ratio | 0.40 |
| Forward PEG | 0.40 |
| Price/Book | -303.23 |
| Price/Sales | 11.17 |
| Price/FCF | -9.87 |
| Price/Op Cash Flow | -10.07 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.4520 |
| Debt/Equity | -55.9111 |
| Debt/Capital | 1.0182 |
| Long-Term Debt/Capital | 1.0199 |
| Financial Leverage | -123.71 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.32 |
| Operating Cash Flow Ratio | -1.423 |
| Operating Cash Flow/Sales | -110.9% |
| Free Cash Flow/Operating Cash Flow | 102.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -7.42 |
| Interest Coverage | -8.8840 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -0.54 |
| Capital Expenditure Coverage | -47.82 |
| Dividend + Capital Expenditure Coverage | -47.82 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.45 |
| EPS | -3.228 |
| Debt/Share | 3.3579 |
| Cash/Share | 5.90 |
| Book Value/Share | -0.05 |
| Tangible BV/Share | -0.05 |
| Equity/Share | -0.05 |
| Operating Cash Flow/Share | -1.604 |
| Capital Expenditure/Share | 0.034 |
| FCF/Share | -1.637 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.958 |
| Earnings Before Tax/EBIT | 0.998 |
| Price/Fair Value | -303.23 |
| Debt/Market Cap | 0.1694 |
| Effective Tax Rate | 4.2% |
| Enterprise Value Multiple | -4.94 |